REGIONS FINANCIAL CORP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 329 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
REGIONS FINANCIAL CORP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$209,663
+103693.6%
5,110
-4.4%
0.00%0.0%
Q4 2022$202
-99.9%
5,3460.0%0.00%0.0%
Q3 2022$236,000
-31.6%
5,346
-42.7%
0.00%
-33.3%
Q1 2022$345,000
+21.5%
9,3230.0%0.00%
+50.0%
Q4 2021$284,000
-10.1%
9,323
-1.1%
0.00%
-33.3%
Q3 2021$316,000
-16.0%
9,4230.0%0.00%0.0%
Q2 2021$376,000
+50.4%
9,423
+113.1%
0.00%
+50.0%
Q4 2020$250,000
+16.3%
4,421
-2.6%
0.00%0.0%
Q3 2020$215,000
-19.8%
4,5410.0%0.00%
-33.3%
Q2 2020$268,000
+24.1%
4,541
-0.6%
0.00%0.0%
Q1 2020$216,000
-21.7%
4,5670.0%0.00%0.0%
Q4 2019$276,000
+0.7%
4,5670.0%0.00%0.0%
Q3 2019$274,000
-3.5%
4,567
+3.3%
0.00%0.0%
Q2 2019$284,000
-19.8%
4,421
+1.1%
0.00%
-25.0%
Q1 2019$354,000
+50.0%
4,3720.0%0.00%
+33.3%
Q4 2018$236,000
+4.4%
4,3720.0%0.00%
+50.0%
Q3 2018$226,000
+24.2%
4,3720.0%0.00%0.0%
Q2 2018$182,000
-7.1%
4,372
-1.4%
0.00%0.0%
Q1 2018$196,000
-12.1%
4,4330.0%0.00%0.0%
Q4 2017$223,000
-0.9%
4,4330.0%0.00%
-33.3%
Q3 2017$225,000
+2.3%
4,433
+2.6%
0.00%0.0%
Q2 2017$220,000
-13.7%
4,321
-18.8%
0.00%0.0%
Q4 2016$255,000
+23.8%
5,321
+4.4%
0.00%0.0%
Q1 2016$206,000
-39.1%
5,096
-6.7%
0.00%
-40.0%
Q4 2015$338,0005,4600.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders